More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$2.39B
EPS
-2
P/E ratio
--
Price to sales
0.41
Dividend yield
2.208%
Beta
1.436105
Previous close
$15.26
Today's open
$15.51
Day's range
$15.44 - $16.03
52 week range
$10.44 - $28.67
show more
CEO
Denise M. Dignam
Employees
5700
Headquarters
Wilmington, DE
Exchange
New York Stock Exchange
Shares outstanding
150498995
Issue type
Common Stock
Materials
Chemicals
Chemours Expands Low-GWP Refrigerant Portfolio for Data Centers
CC expands its low-GWP Opteon refrigerant portfolio to meet rising cooling needs from AI-driven data centers and support decarbonization goals.
Zacks Investment Research • Aug 14, 2026

The Chemours Company (CC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN THE CHEMOURS COMPANY (CC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by emai.
Business Wire • Aug 13, 2026

Securities Fraud Investigation Into The Chemours Company (CC) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CHEMOURS COMPANY (CC), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On Augus.
Business Wire • Aug 13, 2026

Chemours' Q2 Earnings & Revenues Lag Estimates on Lower Volumes
CC's Q2 loss narrows, but lower volumes and sales weigh on results as it outlines a cautious Q3 outlook.
Zacks Investment Research • Aug 11, 2026

Chemours Launches Opteon™ ZE and Opteon™ 515B Refrigerants for Chiller Applications Powering Data Centers, Commercial Buildings, and Other Mission Critical Environments
New additions to the Opteon™ portfolio support high-performance, sustainable cooling solutions in stationary chillers for AI-driven data centers, and commercial HVAC applications WILMINGTON, Del., Aug. 10, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company, today announced the launch of Opteon™ ZE (R-1234ze(E)) and Opteon™ 515B (R-515B) for stationary chiller applications.
PRNewsWire • Aug 10, 2026

New Jersey's $2.5 billion 'forever chemicals' settlements with DuPont, 3M, others win court approval
A federal judge on Friday approved more than $2.5 billion of settlements that New Jersey reached with DuPont , Chemours , Corteva and 3M to resolve claims over pollution attributed to PFAS, also known as “forever chemicals.”
Reuters • Aug 7, 2026

Leading Women-Run Companies Shaping the Future of Business
CNC, DAR, GD, FCEL and CC stocks show how women-led companies are redefining growth with discipline, agility and results.
Zacks Investment Research • Aug 7, 2026

The Chemours Company (CC) Q2 2026 Earnings Call Transcript
The Chemours Company (CC) Q2 2026 Earnings Call Transcript
Seeking Alpha • Aug 6, 2026

Chemours: Close To A 'Perfect' Rotation, With A 'Buy' In Q2 2026 (Rating Upgrade)
Chemours is upgraded to 'BUY' with a $20 PT and $30 fair value, reflecting renewed upside after recent volatility. CC's recent rally was driven by sentiment, not fundamentals, but the company now shows improving liquidity, debt reduction, and solid EBITDA guidance. Risks remain from regulatory liabilities and elevated leverage, but CC's divestment plan and Opteon growth support a high-conviction turnaround thesis.
Seeking Alpha • Aug 6, 2026

Why Chemours Plunged on Wednesday
Chemours disappointed investors with a slight revenue decline in Q2. However, there were some one-off factors that limited revenue in the second quarter.
The Motley Fool • Aug 5, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Chemours Company (The) commission-free¹. Build wealth for the long term using automated trading and transfers.